跳至主要内容
临床试验/NCT07207941
NCT07207941尚未招募不适用

Effect of Probiotics on Quality of Life, Activities of Daily Living and Anxiety in Post Stroke Patients

National University of Malaysia1 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2025年9月30日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
110
试验地点
1
主要终点
Primary Objective

研究概览

简要总结

Research on Effect of probiotics on quality of life, activities of daily living and anxiety in post stroke patients

详细描述

Background:

Stroke survivors often experience reduced quality of life (QoL), impaired activities of daily living (ADL), and high levels of anxiety. Emerging evidence suggests that modulation of the gut-brain axis through probiotics may improve neuropsychological and functional outcomes. However, data from Malaysian populations are lacking.

Objective:

To evaluate the effects of probiotic supplementation compared to placebo on QoL, ADL, anxiety symptoms, and functional outcomes in post-stroke patients.

Study Design:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients diagnosed with moderate ischemic stroke with mRS score of 2-4 from onset of stroke up to 3 months.
  • •Patients aged 18 to 80 years, who are able to read and write in English and/or Bahasa Malaysia
  • •Provide informed consent

排除标准

  • •Patients with aphasia
  • •Patients who have received thrombolysis or mechanical thrombectomy
  • •Gastrointestinal related diseases such as lactose intolerance, coeliac disease, Renal or hepatic insufficiency (Based on recent six-month blood profile)
  • •Progressive neurological disease (Alzheimer's disease, Parkinson's Disease, Motor Neuron Disease)
  • •Pregnancy and breastfeeding.
  • •Secondary cause of stroke- vasculitis, cerebral venous sinus thrombosis, connective tissue disorders
  • •Past history of psychiatric disorders (depression, anxiety)
  • •Recent use of probiotics and allergies to probiotics
  • •Immunosuppressed patients (HIV, malignancy)
  • •Patient with septicemia

研究组 & 干预措施

Placebo

Placebo Comparator

Placebo Control Matching placebo sachets, identical in appearance and schedule.

干预措施: Placebo (Other)

Intervention

Active Comparator

Intervention group HEXBIO MCP Granule probiotics (Lactobacillus acidophilus, L. casei, L. lactis, Bifidobacterium bifidum, B. infantis, B. longum), one sachet twice daily for 3 months.

干预措施: Hexbio (Dietary Supplement)

结局指标

主要结局

Primary Objective

时间窗: 3 months

QoL measured using the Stroke-Specific Quality of Life (SS-QoL) scale. To assess the patient's quality of life, validated Stroke Specific Quality of life (SS-QoL) questionnaire in English version will be used. This questionnaire consists of 12 domains which includes energy, family roles, language, mobility, mood, personality, self-care, social roles, thinking, upper extremity function, vision, and work/productivity. Each question is scored using 5 point Likert scale and the total score is calculated which can range from 49-245. The higher the score, better the quality of life. This questionnaire is validated and requested for permission.

次要结局

  • Secondary objective: modified Rankin scale(3 months)
  • Secondary objectives: Activities of daily living(3 months)
  • Secondary objective: Anxiety Score(3 months)

研究者

发起方
National University of Malaysia
申办方类型
Other
责任方
Principal Investigator
主要研究者

Tan Hui Jan

Consultant Neurologist

National University of Malaysia

研究点 (1)

Loading locations...

相似试验